The Valley Desk

NCT00046254 · Interventional trial

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Overall registry status Completed

Phase 3

Conditions Hip Fracture, Osteoporosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov